Screening and Management of High-risk Populations of Stroke in Dehui City

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

4100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-01-01

Study Completion Date

2017-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This epidemiological survey is to analyze the prevalence rate of stroke and exposure rate of risk factors in sampling population aged 40 years and over (born before December 31,1975) in Dehui City, to provide scientific basis for pertinent prevention and control of stroke in Jilin Province, and to provide valuable data for the high-risk groups to carry out regular follow-up and standardized management.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Stroke Registration of Young Adults in China

NCT03024164

Ischemic Stroke

RECRUITING

Chinese Atherosclerosis Risk Evaluation- Phase II

NCT02017756

Ischemic Stroke Transient Ischemic Attack Carotid Atherosclerotic Disease

UNKNOWN

A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients

NCT05454397

Acute Stroke

UNKNOWN

Quality Control Project of Stroke in Liaoning Province

NCT03507517

Stroke, Ischemic

COMPLETED

Affect of Multiple Health Education on Medication Persistence and Clinical Prognosis of Ischemic Stroke Patients

NCT02140619

Ischemic Stroke Medication Persistence

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebrovascular Accident Stroke Hypertension Diabetes Mellitus Dyslipidemias

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low-risk Group

Low-risk Group is defined as the population with \<3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), but without chronic disease (hypertension, diabetic mellitus, atrial fibrillation or valvular heart disease).

Advice according to primary prevention guidelines on stroke of China

Intervention Type OTHER

Mediate-risk Group

Mediate-risk Group is defined as the population with \<3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), but meanwhile suffer from chronic disease (hypertension, diabetic mellitus, atrial fibrillation or valvular heart disease).

Advice according to primary prevention guidelines on stroke of China

Intervention Type OTHER

High-risk Group

High-risk Group is defined as the population with ≥3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), or population with history of stroke or/and transient ischemic attack.

Advice according to primary prevention guidelines on stroke of China

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Advice according to primary prevention guidelines on stroke of China

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 40 years and over in Dehui City
* Willing to participate in the study and follow-up visits
* Signed an informed consent

Exclusion Criteria

* Life expectancy\<3 years
* Unwilling to participate in the study and follow-up visits
* Living away from Dehui City over 6 months
* Unable to cooperate with examination and questionnaire due to mental disease

Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes